A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

NCT04626635 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

933

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: REGN7075
DRUG: Cemiplimab
DRUG: Platinum-based doublet chemotherapy
DRUG: Bevacizumab
DRUG: Trifluridine-tipiracil

Sponsor

Regeneron Pharmaceuticals